Jump Financial LLC lifted its stake in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) by 57.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 562,376 shares of the company's stock after acquiring an additional 204,985 shares during the quarter. Jump Financial LLC owned 0.23% of Oscar Health worth $7,558,000 at the end of the most recent reporting period.
Other hedge funds have also modified their holdings of the company. Barclays PLC raised its holdings in Oscar Health by 10.8% during the 4th quarter. Barclays PLC now owns 361,062 shares of the company's stock worth $4,852,000 after buying an additional 35,244 shares during the period. Summit Investment Advisors Inc. lifted its position in shares of Oscar Health by 5.8% in the 4th quarter. Summit Investment Advisors Inc. now owns 20,838 shares of the company's stock valued at $280,000 after acquiring an additional 1,141 shares in the last quarter. Zuckerman Investment Group LLC acquired a new position in Oscar Health in the 4th quarter worth approximately $269,000. Raymond James Financial Inc. purchased a new position in Oscar Health during the 4th quarter worth approximately $6,613,000. Finally, Straightline Group LLC purchased a new stake in shares of Oscar Health in the fourth quarter valued at $205,000. 75.70% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
Separately, Wells Fargo & Company lowered Oscar Health from an "overweight" rating to an "equal weight" rating and dropped their price target for the company from $20.00 to $16.00 in a research report on Thursday, March 13th. Two investment analysts have rated the stock with a sell rating, three have given a hold rating, two have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus target price of $20.21.
Get Our Latest Stock Analysis on Oscar Health
Oscar Health Stock Down 4.7 %
OSCR stock traded down $0.57 during mid-day trading on Monday, hitting $11.46. The stock had a trading volume of 714,449 shares, compared to its average volume of 3,854,176. The stock has a market capitalization of $2.87 billion, a price-to-earnings ratio of -572.71 and a beta of 1.75. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.26. Oscar Health, Inc. has a 1-year low of $11.37 and a 1-year high of $23.79. The company has a fifty day moving average of $13.76 and a 200 day moving average of $15.03.
Oscar Health (NYSE:OSCR - Get Free Report) last announced its quarterly earnings results on Tuesday, February 4th. The company reported ($0.62) EPS for the quarter, missing the consensus estimate of ($0.55) by ($0.07). Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. On average, equities analysts expect that Oscar Health, Inc. will post 0.69 EPS for the current fiscal year.
About Oscar Health
(
Free Report)
Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
Further Reading

Before you consider Oscar Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.
While Oscar Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.